title: Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
authors.affiliation: Nephrology Division, Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona, USA.
authors.forename: R
authors.initials: R
authors.lastname: Byrne
authors.forename: S E
authors.initials: SE
authors.lastname: Yost
authors.forename: B
authors.initials: B
authors.lastname: Kaplan
mesh_terms: D016903:Drug Monitoring / Q000379:methods*; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D016377:Organ Transplantation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid